|
1) 田中一郎, 嶋 緑倫. 後天性血友病―本邦における実態と抗第VIII因子自己抗体の免疫生化学的特性―. 臨床血液. 2005; 46: 91-8
|
|
|
|
2) Reding MT, Okita DK, Diethelm-Okita BM, et al. Human CD4＋ T-cell epitope repertoire on the C2 domain of coagulation factor VIII. J Thromb Haemost. 2003; 1: 1777-84
|
|
|
|
|
3) Reding MT, Okita DK, Diethelm-Okita BM, et al. Epitope repertoire of human CD4(＋) T cells on the A3 domain of coagulation factor VIII. J Thromb Haemost. 2004; 2: 1385-94
|
|
|
|
|
|
4) Prescott R, Nakai H, Saenko EL, et al. The inhibitor antibody response is more complex in hemophilia A patients than in most nonhemophiliacs with factor VIII autoantibodies. Blood. 1997; 89: 3663-71
|
|
|
|
|
|
5) Reding MT, Lei S, Lei H, et al. Distribution of Th1- and Th2-induced anti-factor VIII IgG subclasses in congenital and acquired hemophilia patients. Thromb Haemost. 2002; 88: 568-75
|
|
|
|
|
|
6) Pavlova A, Diaz-Lacava A, Zeitler H, et al. Increased frequency of the CTLA-4 49 A/G polymorphism in patients with acquired haemophilia A compared to healthy controls. Haemophilia. 2008; 14: 355-60
|
|
|
|
|
|
7) Pratt KP, Thompson AR. B-cell and T-cell epitopes in anti-factor VIII immune responses. Clin Rev Allergy Immunol. 2009 (online)
|
|
|
|
|
|
8) Lacroix-Desmazes S, Navarrete AM, André S, et al. Dynamics of factor VIII interactions determine its immunologic fate in hemophilia A. Blood. 2008; 112: 240-9
|
|
|
|
|
|
9) Algiman M, Dietrich G, Nydegger UE, et al. Natural antibodies to factor VIII (anti-hemophilic factor) in healthy individuals. Proc Natl Acad Sci U S A. 1992; 89: 3795-9
|
|
|
|
|
|
10) Batlle J, Gómez E, Rendal E, et al. Antibodies to factor VIII in plasma of patients with hemophilia A and normal subjects. Ann Hematol. 1996; 72: 321-6
|
|
|
|
|
|
11) Hu GL, Okita DK, Diethelm-Okita BM, et al. Recognition of coagulation factor VIII by CD4＋ T cells of healthy humans. J Thromb Haemost. 2003; 1: 2159-66
|
|
|
|
|
|
12) Matzinger P. Tolerance, danger, and the extended family. Annu Rev Immunol. 1994; 12: 991-1045
|
|
|
|
|
|
13) Astermark J, Wang X, Oldenburg J, et al. Polymorphisms in the CTLA-4 gene and inhibitor development in patients with severe hemophilia A. J Thromb Haemost. 2007; 5: 263-5
|
|
|
|
|
|
14) Matsumoto T, Shima M, Fukuda K, et al. Immunological characterization of factor VIII autoantibodies in patients with acquired hemophilia A in the presence or absence of underlying disease. Thromb Res. 2001; 104: 381-8
|
|
|
|
|